Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study

被引:5
作者
Bonnin, Sophia [1 ]
Radosevich, John J. [1 ]
Lee, Yong Gu [1 ]
Feldman, Jeremy P. [2 ]
Barletta, Jeffrey F. [3 ]
机构
[1] Dign Hlth St Josephs Hosp & Med Ctr, 350 W Thomas Rd, Phoenix, AZ 85013 USA
[2] Arizona Pulm Specialists, 3330 N 2nd St, Phoenix, AZ 85012 USA
[3] Midwestern Univ, Coll Pharm Glendale, 19555 N 59th Ave, Glendale, AZ 85308 USA
关键词
Sepsis; Septic shock; Corticosteroids; Hydrocortisone; Vasopressors; Intensive care unit; Shock recurrence; SEVERE SEPSIS; DOUBLE-BLIND; GUIDELINES; THERAPY; FLUDROCORTISONE; INSUFFICIENCY; MANAGEMENT; STEROIDS;
D O I
10.1016/j.jcrc.2020.12.001
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: This study aims to describe differences in shock reversal between hydrocortisone 200 mg and 300 mg per day dosing regimens in patients with septic shock. Methods: This is a multi-center retrospective study including patients admitted to intensive care units with septic shock receiving vasopressors and hydrocortisone between 2013 and 2018. We compared patients who received low dose hydrocortisone (50 mg every 6 h) versus high dose hydrocortisone (100 mg every 8 h) on the primary outcome of shock reversal. Results: 319 patients (low dose group, n = 134 and high dose group, n = 185) were included. In the multivariate regression model, high-dose steroids were associated with shock reversal [OR (95% CI) = 2.278 (1.063-4.880), p = 0.034]. This was not confirmed in the propensity score matched analysis [OR (95% CI) =2.202 (0.892-5.437), p = 0.087]. High dose steroids were associated with a lower need for additional vasopressor ther-apy (22% vs. 34%, p = 0.012) and lower shock recurrence (6.7% vs. 16%, p = 0.013), which was confirmed with propensity score matching. Conclusions: Low and high dose hydrocortisone have similar rates of shock reversal in septic shock patients. Hy-drocortisone 100 mg every 8 h may reduce rates of recurrence of shock and reduce the need for additional vasopressors. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 22 条
[1]   Hydrocortisone plus Fludrocortisone for Adults with Septic Shock [J].
Annane, D. ;
Renault, A. ;
Brun-Buisson, C. ;
Megarbane, B. ;
Quenot, J. -P. ;
Siami, S. ;
Cariou, A. ;
Forceville, X. ;
Schwebel, C. ;
Martin, C. ;
Timsit, J. -F. ;
Misset, B. ;
Benali, M. Ali ;
Colin, G. ;
Souweine, B. ;
Asehnoune, K. ;
Mercier, E. ;
Chimot, L. ;
Charpentier, C. ;
Francois, B. ;
Boulain, T. ;
Petitpas, F. ;
Constantin, J. -M. ;
Dhonneur, G. ;
Baudin, F. ;
Combes, A. ;
Bohe, J. ;
Loriferne, J. -F. ;
Amathieu, R. ;
Cook, F. ;
Slama, M. ;
Leroy, O. ;
Capellier, G. ;
Dargent, A. ;
Hissem, T. ;
Maxime, V. ;
Bellissant, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09) :809-818
[2]   A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin [J].
Annane, D ;
Sébille, V ;
Troché, G ;
Raphaël, JC ;
Gajdos, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (08) :1038-1045
[3]   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [J].
Annane, D ;
Sébille, V ;
Charpentier, C ;
Bollaert, PE ;
François, B ;
Korach, JM ;
Capellier, G ;
Cohen, Y ;
Azoulay, E ;
Troché, G ;
Chaumet-Riffaut, P ;
Bellissant, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (07) :862-871
[4]   Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 [J].
Annane, Djillali ;
Pastores, Stephen M. ;
Rochwerg, Bram ;
Arlt, Wiebke ;
Balk, Robert A. ;
Beishuizen, Albertus ;
Briegel, Josef ;
Carcillo, Joseph ;
Christ-Crain, Mirjam ;
Cooper, Mark S. ;
Marik, Paul E. ;
Meduri, Gianfranco Umberto ;
Olsen, Keith M. ;
Rodgers, Sophia C. ;
Russell, James A. ;
Van den Berghe, Greet .
CRITICAL CARE MEDICINE, 2017, 45 (12) :2078-2088
[5]   Reversal of late septic shock with supraphysiologic doses of hydrocortisone [J].
Bollaert, PE ;
Charpentier, C ;
Levy, B ;
Debouverie, M ;
Audibert, G ;
Larcan, A .
CRITICAL CARE MEDICINE, 1998, 26 (04) :645-650
[6]   A CONTROLLED CLINICAL-TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN THE TREATMENT OF SEVERE SEPSIS AND SEPTIC SHOCK [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (11) :653-658
[7]   Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study [J].
Briegel, J ;
Forst, H ;
Haller, M ;
Schelling, G ;
Kilger, E ;
Kuprat, G ;
Hemmer, B ;
Hummel, T ;
Lenhart, A ;
Heyduck, M ;
Stoll, C ;
Peter, K .
CRITICAL CARE MEDICINE, 1999, 27 (04) :723-732
[8]  
Briegel J, 2001, J AM SOC NEPHROL, V12, pS70
[9]   US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock [J].
Bruno, Jeffrey J. ;
Dee, Brian M. ;
Anderegg, Brent A. ;
Hernandez, Mike ;
Pravinkumar, S. Egbert .
JOURNAL OF CRITICAL CARE, 2012, 27 (04) :351-361
[10]   Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock [J].
Buckley, Mitchell S. ;
Barletta, Jeffrey F. ;
Smithburger, Pamela L. ;
Radosevich, John J. ;
Kane-Gill, Sandra L. .
PHARMACOTHERAPY, 2019, 39 (03) :382-398